Soyoung Park

General Partner

2024

At 1004 Venture Partners, we are dedicated to driving transformative innovations that enhance healthy aging and longevity. Our mission is to invest in groundbreaking technologies and visionary entrepreneurs who are redefining the future of health. By focusing on pre-seed, seed, and series A stage companies, we empower the next generation of pioneers in the longevity sector. Our strategic investments fuel the development of solutions that promote longer, healthier lives. Join us in shaping a future where aging is not just about living longer but living better.

Investment Due Diligence Director

2023

Investment Due Diligence Manager

2020 - 2023

Analyst in Residence

2020 - 2020

HealthTech Capital is a group of private investors dedicated to funding and mentoring new "HealthTech" startups at the intersection of healthcare with digital technologies.

Venture Partner

2023

VU Venture Partners is a multi-stage and multi-sector investment fund with offices in San Francisco and Hong Kong. VU's team is led by J. Skyler Fernandes, Andrew Zalasin, and James Zhang - top-performing investors with 45+ years of VC experience and a large number of successful investments such as Beyond Meat, Facebook, Uber, Twitter, Venmo, Oculus, Wish, Oscar, etc. We invest in Pre-seed through Series B rounds. Our initial investments range from $100K-$1M, and we will invest up to $10M in follow-on rounds. If you or anyone you know are raising capital for a startup, especially if it has enormous potential, please don't hesitate to reach out! #VC #VentureCapital #VUVenturePartners #VentureUniversity #VCTraining #Startups #Funding #Investments #PE #PrivateEquity

Clinical FP&A Senior Manager, R&D Finance, Rare Disease

2022 - 2023

Post-merger integration of the sickle cell disease equity Oxbryta and two late-stage drug development assets

Finance Lead, Clinical Development Finance Planning and Analysis Senior Manager

2021 - 2023

GBT is driven by a deep and urgent desire to improve the care of Sickle Cell Disease (SCD) patients. Beyond developing medicines, we are working to shine a bright light on the disparities and inequalities faced by people living with Sickle Cell Disease (SCD). Global Clinical Product Development Financial Planning & Analysis

Finance Project Consultant

2020 - 2020

Cost structure building for a new gene therapy pipeline

Corporate Controller Consultant, Associate Director of Accounting

2018 - 2018

Corporate Controller Consultant

2017 - 2017

Finance Project Consultant

2017 - 2017

Controller of Strategic Projects, Global Operations

2014 - 2016

Strategic global operation cost optimization projects for a $110M cost reduction

Controller of California, Global Operations

2012 - 2014

Post-acquisition Integration, new R&D pipeline commercialization, and SAP ERP system implementation